Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agios Pharmaceuticals

40.00
-0.3500-0.87%
Post-market: 40.000.00000.00%16:32 EDT
Volume:824.55K
Turnover:33.30M
Market Cap:2.32B
PE:3.49
High:41.19
Open:40.70
Low:39.96
Close:40.35
Loading ...

Director David Scadden Reports Disposal of Common Shares of Agios Pharmaceuticals Inc

Reuters
·
16 Jul

Agios Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Jay T. Backstrom

Reuters
·
11 Jul

Agios Appoints DR. Jay Backstrom to Board of Directors

THOMSON REUTERS
·
08 Jul

Press Release: Agios Appoints Dr. Jay Backstrom to Board of Directors

Dow Jones
·
08 Jul

Chief Medical Officer Sarah Gheuens Reports Disposal of Agios Pharmaceuticals Common Shares

Reuters
·
04 Jul

CEO Brian Goff Reports Disposal of Common Shares in Agios Pharmaceuticals Inc

Reuters
·
27 Jun

Agios Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
19 Jun

Agios Pharmaceuticals price target lowered to $56 from $61 at H.C. Wainwright

TIPRANKS
·
10 Jun

Agios Pharmaceuticals Inc. Enters Pan-European Partnership with Avanzanite to Launch PYRUKYND® for Rare Blood Disorders

Reuters
·
09 Jun

Agios Pharmaceuticals Inc : JP Morgan Cuts Target Price to $38 From $43

THOMSON REUTERS
·
07 May

Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
02 May

Agios Pharmaceuticals price target lowered to $71 from $74 at Scotiabank

TIPRANKS
·
02 May

Agios' Q1 Loss Narrower Than Expected, Revenues Lag Estimates

Zacks
·
02 May

Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025

GlobeNewswire
·
02 May

Agios Pharmaceuticals Inc (AGIO) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid ...

GuruFocus.com
·
02 May

Agios Pharmaceuticals’ Earnings Call: Optimism Amid Challenges

TIPRANKS
·
02 May

Agios Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $61 From $58

THOMSON REUTERS
·
01 May

Agios Pharmaceuticals Shares Down After Q1 Net Loss Widens, Revenue Misses Estimates

MT Newswires Live
·
01 May

Stock Track | Agios Pharmaceuticals Plummets 5.41% as Q1 Revenue Misses Estimates Despite Narrower Loss

Stock Track
·
01 May

Stock Track | Agios Pharmaceuticals Plummets 5.41% Pre-Market on Q1 Revenue Miss

Stock Track
·
01 May